# Omidenepag isopropyl

## Eybelis 0.002% 2.5mL ophthalmic solution

| TAH Drug Code      | [EEYB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EEYB)                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment for open-angle glaucoma, ocular hypertension - raised intraocular pressure.                                                                                                                                                                                                                                                                                                                       |
| Dosing             | For ophthalmic use only. Administer 1 drop in affected eye(s) once daily in the evening. Do not exceed one drop per affected eye per day.                                                                                                                                                                                                                                                                   |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Patients without a natural lens or those who have undergone intraocular lens (IOL) implantation. Concomitant use with tafluprost. Hypersensitivity to the active ingredient or any excipients.                                                                                                                                                                                                              |
| Adverse Effects    | Common: Headache (2%), Application site pain (3%), Blurred vision (4%), Conjunctival hyperemia (9%), Dry eyes (3%), Eye irritation (1%), Hyperemia of eye (2%), Pain in eye (2%), Photophobia (5%), Superficial punctate keratitis (2%), Visual impairment (1%) Serious: Application site pigmentation changes, Iris/periorbital tissue/eyelash, Eyelash formation, Changes, Macular retinal edema, Uveitis |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/omidenepag-isopropyl-drug-information)                                                                                                                                                                                                                                                                                                                         |

